Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1153 USD | -16.99% | -58.84% | -94.56% |
Jun. 04 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Jun. 04 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | 200K | Sales 2025 * | 1M | Capitalization | 1.53M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -12M | EV / Sales 2024 * | 7.66 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.53 x |
P/E ratio 2024 * |
-0.11
x | P/E ratio 2025 * |
-0.11
x | Employees | 21 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.85% |
Latest transcript on ENDRA Life Sciences Inc.
1 day | -2.86% | ||
1 week | -56.82% | ||
Current month | -57.14% | ||
1 month | -64.71% | ||
3 months | -89.96% | ||
6 months | -91.40% | ||
Current year | -94.56% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 14-12-31 | |
Irina Pestrikova
DFI | Director of Finance/CFO | 38 | 21-06-17 |
Michael Thornton
CTO | Chief Tech/Sci/R&D Officer | 55 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 13-06-30 | |
Alexander Tokman
BRD | Director/Board Member | 62 | 07-12-31 |
Michael Harsh
BRD | Director/Board Member | 69 | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 0.1153 | -16.99% | 53,194,301 |
24-06-05 | 0.1389 | +63.41% | 485,625,524 |
24-06-04 | 0.085 | -60.83% | 72,337,768 |
24-06-03 | 0.217 | -19.33% | 622,458 |
24-05-31 | 0.269 | -3.96% | 301,267 |
Delayed Quote Nasdaq, June 06, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.56% | 1.53M | |
+55.55% | 59.34B | |
+43.17% | 40.24B | |
-4.71% | 39.88B | |
-5.56% | 28.55B | |
+13.76% | 27.26B | |
-22.00% | 19.23B | |
+31.50% | 12.61B | |
+2.16% | 12.49B | |
+25.70% | 12.28B |
- Stock Market
- Equities
- NDRA Stock